1. Disease Activity Assessment Across the RA Continuum

5. MBDA Development

6. 14-3-3η Background and Use

7. 14-3-3η Background and Use (cont)

8. Case 1 Early RA

9. Case 1 Assessments

10. Role of 14-3-3η in Diagnostic Testing for RA

13. MBDA in Patients with Low CRP

14. Methods

15. Findings

16. Case 2 Established RA

17. MBDA Scores Predict Rapid Radiographic Progression

18. Early RA MBDA Scores vs Baseline CRP, ESR, or DAS28-ESR

19. Persistently High MBDA Scores and Risk for RRP

20. Early and Significant Change in Mean MBDA Score 2 Weeks After Initiation of Therapy

21. Abstract Number 618

22. Methods

23. Findings

24. Case 3 Patient in Remission

25. MBDA in RA Patients With LDA or Remission REMIRA Cohort

26. Findings

27. Predicting Successful Discontinuation With MBDA Score

28. MBDA and ACPA in Remission, RETRO

29. MBDA in Predicting Flare, POET

30. POET Scores at Baseline

31. POET Findings, 12 Months

32. POET, MBDA Predicts Flare

33. POET Subanalysis

34. Panel Discussion

35. Abbreviations

36. Abbreviations (cont)